Clinical Value of Metagenomics Next-Generation Sequencing in Antibiotic Resistance of a Patient with Severe Refractory Mycoplasma pneumoniae Pneumonia: A Case Report
Lianjun Lin,Ruixue Zhang,Zhi Zhang,Yujun Chang,Rongnan Lin,Haiwei Dou,He Wang,Yuchuan Wang,Bo Zheng
DOI: https://doi.org/10.2147/IDR.S419873
2023-07-14
Infection and Drug Resistance
Abstract:Lianjun Lin, 1, &ast Ruixue Zhang, 1, &ast Zhi Zhang, 2, 3 Yujun Chang, 2, 3 Rongnan Lin, 2, 3 Haiwei Dou, 4 He Wang, 5 Yuchuan Wang, 6 Bo Zheng 7 1 Geriatric Department, Peking University First Hospital, Beijing, People's Republic of China; 2 National Engineering Research Center for Beijing Biochip Technology, Beijing, People's Republic of China; 3 CapitalBio Corporation, Beijing, People's Republic of China; 4 Beijing Friendship Hospital, Capital Medical University, Beijing Tropical Medicine Research Institute, Beijing, People's Republic of China; 5 Department of Imaging, Peking University First Hospital, Beijing, People's Republic of China; 6 Department of Cardiology, Beijing Shijitan Hospital, Beijing, People's Republic of China; 7 Institute of Clinical Pharmacology, Peking University First Hospital, Beijing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhi Zhang, National Engineering Research Center for Beijing Biochip Technology, Changping District, Beijing, 102206, People's Republic of China, Email Lianjun Lin, Geriatric Department, Peking University First Hospital, Xishiku Avenue 8, Xicheng District, Beijing, 100034, People's Republic of China, Email Background: Mycoplasma pneumoniae is an important infectious pathogen of lower respiratory tract infection in children and adolescents. Macrolide resistant M. pneumoniae (MRMP) has become increasingly prevalent, and identifying pathogen resistance genes is crucial for treatment. Case Presentation: We report a patient with severe refractory M. pneumoniae pneumonia (MPP). The failure of initial clinical treatment prompted the re-analysis of metagenomic next-generation sequencing (mNGS) data for macrolide-resistant gene. Macrolide-resistance 23S ribosomal RNA gene was confirmed with read depth of 64 X for the A2063G mutation, which can decrease the affinity of macrolide with M. pneumoniae ribosome resulting in macrolide resistance. Furthermore, antimicrobial susceptibility testing demonstrated that M. pneumoniae was resistant to macrolide. PCR confirmatory test about M. pneumoniae resistance A2063G mutation, clinical treatment course and prognosis with altered treatment strategy, and M. pneumoniae antimicrobial susceptibility confirmed that the severe refractory MPP was due to macrolide resistant M. pneumoniae . Conclusion: As a new molecular level detection, mNGS is an effective method for detecting M. pneumoniae resistance genes. Early recognition of macrolide resistance and suitable antibiotics strategy is of vital importance for the prognosis of severe refractory MPP. Keywords: Mycoplasma pneumoniae , pneumonia, macrolide-resistant gene, metagenomic next-generation sequencing, A2063G mutation Mycoplasma pneumoniae is an important infectious pathogen of lower respiratory tract infection in children and adolescents. M. pneumoniae pneumonia (MPP) accounts for 30% to 40% of community-acquired pneumonia in children. 1 The first-line antibiotic for treating MPP is macrolides. Due to the widespread use of macrolides, instances of M. pneumoniae resistant to macrolides are increasingly observed. 2 As a new molecular diagnostic technology, mNGS can rapidly detect the drug-resistant genes of pathogens, thus avoiding the abuse of antibiotics and shortening the course of disease. This study presents a case of severe refractory MPP in which mNGS was utilized to detect the drug-resistant gene of M. pneumoniae , guiding the course of treatment. An 8-year-old girl with a 5-day history of fever and 4-day history of cough was admitted into our hospital. She had a medical history of pneumonia five years ago. On examination, we found her with a temperature of 39.8°C, pulse rate of 99 bpm, respiratory rate of 26 breaths per min, blood pressure of 102/65mmHg and blood oxygen saturation of 97%. Chest X ray and CT showed consolidation and multiple ground-glass density opacity in right lower lobe, and right pleural effusion, which were the signs of pneumonia (Figure 1). Figure 1 Timeline of the clinical course of the case and identification of A2063G mutation. Notes : The change of temperature, CRP, chest X-ray and CT, antimicrobial therapy, and mNGS A2063G mutation were shown in the whole clinical course. Laboratory investigations showed routine blood: WBC 3.78*10^9/L (normal range: 5–12), N% 71.7% (normal range: 25–60). CRP 54mg/L (normal range: 0–8). PCT 0.12ng/ -Abstract Truncated-
pharmacology & pharmacy,infectious diseases